|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Gain on forgiveness of payables | |||||
| Stock-based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued payroll and related liabilities | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net borrowings (repayments) under line of credit | |||||
| Principal repayments under finance lease | |||||
| Payments on notes payable | |||||
| Proceeds from issuance of common stock, net | |||||
| Proceeds from exercise of stock options and warrants | |||||
| Proceeds from issuance of common stock and warrants, net | |||||
| Proceeds from exercise of stock options | |||||
| Payments for taxes related to net share settlement of equity awards | |||||
| Net cash provided by financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
Loading...